Thomas J. Fountaine

CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy

Terry J. Fry, Nirali N. Shah, Rimas J. Orentas et al. · Nature Medicine · 2017 · 1.3K citations · Full text

Allergy, Autoimmune Disease, Cd19-targeted Car Immunotherapy +9

CD19 CAR immune pressure induces B-precursor acute lymphoblastic leukaemia lineage switch exposing inherent leukaemic plasticity

Elad Jacoby, Sang M. Nguyen, Thomas J. Fountaine et al. · Nature Communications · 2016 · 411 citations · Full text

Preclinical Development of Bivalent Chimeric Antigen Receptors Targeting Both CD19 and CD22

Haiying Qin, Sneha Ramakrishna, Sang M. Nguyen et al. · Molecular Therapy — Oncolytics · 2018 · 271 citations · Full text

Multispectral imaging of clinically relevant cellular targets in tonsil and lymphoid tissue using semiconductor quantum dots

Thomas J. Fountaine, Stephen Wincovitch, David Geho et al. · Modern Pathology · 2006 · 142 citations · Full text

Tissue Imaging, Engineering, Microscopy +10

IgD Positive L&H Cells Identify a Unique Subset of Nodular Lymphocyte Predominant Hodgkin Lymphoma

Sonam Prakash, Thomas J. Fountaine, Mark Raffeld et al. · The American Journal of Surgical Pathology · 2006 · 75 citations

Immunodeficiencies, Immunology, Rare B-cell Lymphoma +17